How mothers pass certain antibodies to their babies during pregnancy
Part of Immune system & allergy clinical trials.
This study looks at whether mothers pass certain antibodies through the placenta to their babies. It aims to understand how these antibodies travel from mother to child.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be pregnant and over 18 years old.
- Your pregnancy must be less than 30 weeks along.
- You need to have a condition linked to these antibodies (like lupus, thyroid disease, or type 1 diabetes) or know you have them.
- You must plan to give birth at the study hospital.
- You must be covered by French Social Security.
- You cannot have had a blood transfusion in the last 2 months, or have had an organ transplant, or be on certain treatments like chemotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at a protein called type I interferon, which is often too high in people with autoimmune diseases. The goal is to better understand how it relates to these conditions, which may help improve future treatments.
This study looks at how the immune system may contribute to ongoing placenta inflammation in certain pregnancy histories. It may help researchers better understand causes behind pregnancy loss and related placental complications, using past placenta/tissue samples.
This study looks for biological markers in the mother's blood that might predict how exposure to inflammation during pregnancy could change a baby's brain development. The goal is to understand these effects in healthy pregnancies and those with certain inflammatory conditions.
This study looks at how the immune system helps the body accept a pregnancy. It involves blood samples from people who are pregnant or going through IVF/ICSI, or who have had a miscarriage.
This study is for adults whose immune system has trouble fighting viruses due to specific antibodies or a genetic condition. Researchers want to follow these people over time to better understand the condition and improve care.
This trial studies whether giving your own immune cells (PBMC) to the uterus, modified with interferon (IFN‑t), can improve how endometrial (uterine lining) cells behave during infertility treatment. It may help some people with primary infertility who are undergoing assisted reproduction.
Hear when a new Woman Suffering From a Pathology Frequently Associated With the Presence of These Anti-autoantibodies Type-I Interferons trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.